Keloid scar. Hypertrophic scar
Conditions
Interventions
Intervention 1: Intervention group 1: Silicone gel (Kelo-cort™
Advanced Bio-Technologies, Silverdale, WA, USA) Administration of silicone gel ointment on scar from the day of suture removal (ten day), the treatment was applied one time daily, half a fingertip for
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: male gender aged between 18-45 year able to read and write informed consent and questionnaire
Exclusion criteria
Exclusion criteria: mental disorders peripheral vascular diseases acute viral diseases men who developed surgical complications such as wound infection men who had a history of hypertrophic or keloid scarring in upper extremity men who were taking chemotherapeutic agents or other medications that would affect wound healing men who had comorbidities such as contractive skin disorders (e.g., scleroderma) men who had allergy to silicone or onion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Height of scar. Timepoint: 4 months after the start of intervention. Method of measurement: With a ruler and scoring based on the Vancouver scar scale.;Vascularity of scar. Timepoint: 4 months after the start of intervention. Method of measurement: Observation and evaluation of post-white fill velocity due to pressure and scoring based on the Vancouver scar scale.;Pliability of scar. Timepoint: 4 months after the start of intervention. Method of measurement: Touch and scoring based on the Vancouver scar scale.;Pigmentation of scar. Timepoint: 4 months after the start of intervention. Method of measurement: view and scoring based on the Vancouver scar scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEsmail Hassanpour
Shahid Beheshti University of Medical Sciences
Outcome results
None listed